Cochrane Abstracts
Rituximab for treating inhibitors in people with inherited severe hemophilia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rituximab for Treating Inhibitors in People With Inherited Severe Hemophilia." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436979/all/Rituximab_for_treating_inhibitors_in_people_with_inherited_severe_hemophilia.
Rituximab for treating inhibitors in people with inherited severe hemophilia. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436979/all/Rituximab_for_treating_inhibitors_in_people_with_inherited_severe_hemophilia. Accessed March 19, 2025.
Rituximab for treating inhibitors in people with inherited severe hemophilia. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436979/all/Rituximab_for_treating_inhibitors_in_people_with_inherited_severe_hemophilia
Rituximab for Treating Inhibitors in People With Inherited Severe Hemophilia [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436979/all/Rituximab_for_treating_inhibitors_in_people_with_inherited_severe_hemophilia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rituximab for treating inhibitors in people with inherited severe hemophilia
ID - 436979
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436979/all/Rituximab_for_treating_inhibitors_in_people_with_inherited_severe_hemophilia
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
